Two Sigma Securities, LLC Bristol Myers Squibb CO Put Options Transaction History

Two Sigma Securities, LLC

$5.78 Billion
Q3 2024

Put Options

25 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$39.66 - $51.75 $8.67 Million - $11.3 Million	-218,700 Reduced 50.53%	214,100 $11.1 Million
Q2 2024 Aug 14, 2024	BUY	$40.25 - $52.99 $6.25 Million - $8.23 Million	155,400 Added 56.02%	432,800 $18 Million
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $902,023 - $1.02 Million	18,800 Added 7.27%	277,400 $15 Million
Q4 2023 Feb 14, 2024	SELL	$48.48 - $57.85 $8.75 Million - $10.4 Million	-180,400 Reduced 41.09%	258,600 $13.3 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $21.9 Million - $24.5 Million	379,100 Added 632.89%	439,000 $25.5 Million
Q2 2023 Aug 14, 2023	SELL	$63.71 - $70.74 $732,665 - $813,509	-11,500 Reduced 16.11%	59,900 $3.83 Million
Q1 2023 May 15, 2023	BUY	$65.71 - $74.53 $282,553 - $320,479	4,300 Added 6.41%	71,400 $4.95 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $2.87 Million - $3.4 Million	41,900 Added 166.27%	67,100 $4.83 Million
Q3 2022 Nov 14, 2022	SELL	$0.13 - $76.84 $16,094 - $9.51 Million	-123,800 Reduced 83.09%	25,200 $1.79 Million
Q2 2022 Aug 15, 2022	BUY	$72.62 - $79.98 $6.51 Million - $7.17 Million	89,700 Added 151.26%	149,000 $11.5 Million
Q1 2022 May 16, 2022	BUY	$61.48 - $73.72 $3.18 Million - $3.82 Million	51,800 Added 690.67%	59,300 $4.33 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $193,068 - $225,072	3,600 Added 92.31%	7,500 $468,000
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $3.76 Million - $4.4 Million	-63,500 Reduced 94.21%	3,900 $231,000
Q2 2021 Aug 16, 2021	BUY	$61.91 - $67.42 $2.45 Million - $2.66 Million	39,500 Added 141.58%	67,400 $4.5 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $57,740 - $65,430	1,000 Added 3.72%	27,900 $1.73 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $57,430 - $63,640	1,000 Added 3.86%	26,900 $1.62 Million
Q2 2020 Sep 10, 2020	SELL	$54.82 - $64.09 $1.27 Million - $1.49 Million	-23,200 Reduced 47.25%	25,900 $1.52 Million
Q1 2020 May 15, 2020	SELL	$46.4 - $67.43 $7.85 Million - $11.4 Million	-169,200 Reduced 77.51%	49,100 $2.74 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $295,260 - $385,140	6,000 Added 2.83%	218,300 $14 Million
Q2 2019 Aug 14, 2019	BUY	$44.62 - $49.34 $8.4 Million - $9.29 Million	188,200 Added 780.91%	212,300 $9.63 Million
Q4 2018 Feb 14, 2019	SELL	$48.76 - $63.23 $4.56 Million - $5.91 Million	-93,500 Reduced 79.51%	24,100 $1.25 Million
Q3 2018 Nov 14, 2018	SELL	$55.19 - $62.25 $8.53 Million - $9.62 Million	-154,500 Reduced 56.78%	117,600 $7.3 Million
Q2 2018 Aug 14, 2018	BUY	$50.53 - $62.98 $4.46 Million - $5.55 Million	88,200 Added 47.96%	272,100 $15.1 Million
Q1 2018 May 15, 2018	BUY	$59.92 - $68.98 $10.2 Million - $11.8 Million	170,700 Added 1293.18%	183,900 $11.6 Million
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $791,208 - $862,619	13,200	13,200 $809,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.16 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.37 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.53 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Account